Bivigam®
Bivigam® is an Immune Globulin Intravenous (Human), 10% Liquid, indicated for the treatment of primary humoral immunodeficiency (PI). This includes, but is not limited to, the humoral immune defect in common variable immunodeficiency (CVID), X linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: ADMA Biologic |
CLASS: Immune Globulin |
PRESCRIBED BY: Neurologists |
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Administered every three to four weeks. |
Length of infusion: One to several hours, depending on the dose |
FOR MORE INFORMATION: |
